Remove Court Remove Court Decisions Remove West Virginia
article thumbnail

Canada: Key Takeaways From U.S. Supreme Court Decision In West Virginia v. EPA - Fasken

Mondaq

The CPP was an initiative proposed by the EPA during the Obama presidency in 2015.

article thumbnail

United States: Supreme Court Decision Casts Doubt On SEC's Climate Proposal And Other Regulatory Initiatives - Mayer Brown

Mondaq

Supreme Court decided West Virginia et al. On June 30, 2022, the U.S. Environmental Protection Agency, holding that the EPA lacks authority under Section 7411(d) of the.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

United States: ‘West Virginia' And ‘Chevron': The Supreme Court Cuts Back On Agency Deference - Winston & Strawn LLP

Mondaq

Supreme Court's decision in Chevron v. NRDC (1984) is a longstanding source of controversy. Some proponents of the doctrine argue that it facilitates our Constitution's separation of powers.

article thumbnail

Justices' Climate Ruling May Transform Administrative Law

Law 360

Supreme Court in West Virginia v. Environmental Protection Agency has shed light on how the court's decision could significantly limit the federal government's efforts to address climate change, and reshape administrative law and the separation of powers, say Matthew Sinkman and Andrew Alessandro at Gibbons.

article thumbnail

EPA Ruling Signals Arrival Of 'Major Questions Doctrine'

Law 360

Supreme Court's decision in West Virginia v. While the specific subject of the U.S.

article thumbnail

More Venue and Corporate Games: This time with ANDA filing

Patently O

The 2017 Supreme Court decision in TC Heartland gave renewed teeth to the venue statute governing litigation. Here, Mylan created its ANDA documents at its West Virginia office and submitted them electronically from that location. This argument was quickly rejected by the court. (2) Celgene Corp. owns MPI.

Statute 95
article thumbnail

D.C. Circuit Sides with Manufacturers in Latest 340B Contract Pharmacy Case

FDA Law Blog

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. By Sophia R. Gaulkin & Alan M.